Zbyszek Darzynkiewicz

Last updated
Zbyszek Darzynkiewicz
12-L9206555.jpg
Born
Zbigniew Dierżykraj Darżynkiewicz

May 12, 1936
Dzisna (Wilno Voivodeship), Poland
DiedFebruary 28, 2021(2021-02-28) (aged 84)
CitizenshipAmerican (naturalized 1976)
Alma materMedical University of Warsaw, Poland
Known forThe development of cytometry methods for single-cell analysis; the TUNEL assay
SpouseElizabeth T. Darzynkiewicz
ChildrenRichard B. Darzynkiewicz, Robert J. Darzynkiewicz
AwardsDistinguished Service Award, International Society for Analytical Cytology (ISAC), Officer's Cross of the Order of Merit of the Republic of Poland
Scientific career
Thesis Studies of the Mechanism of Teratogenic Action of Insulin on Chicken Embryo. (1966)
Academic advisorsKazimierz Ostrowski

Zbigniew (Zbyszek) Darzynkiewicz ( ORCID   0000-0002-2040-7081) (Polish pronunciation: [zbiɡ.ɲɛfdaʐɨŋkʲɛvit͡ʂ] ; born May 12, 1936, in Dzisna, Wilno Voivodeship, Poland [1] died February 28, 2021) [2] was a Polish-American cell biologist active in cancer research and in developing new methods in histochemistry for flow cytometry. [3] [4] [5] [6]

Contents

Early life and education

From 1945 to 1949, Darzynkiewicz attended a primary school in Dzierżoniów, Poland. He spent his high school years (1949–1953) in Skarżysko-Kamienna, Poland. His application to the University of Warsaw's Department of Physics was denied by the communist Social Justice Committee, who viewed him as a "enemy of the people." However, following the intervention of Regina Uszyńska, his high school principal, Darzynkiewicz was permitted to submit an application to the Medical University of Warsaw in the fall of 1953. [7] [8]

He earned his M.D. from the Medical University of Warsaw, Poland (1953–1960). From 1962 to 1965, he was a predoctoral fellow at the Department of Histology, Medical University of Warsaw. From 1965 to 1966, he was a visiting scientist at the Department of Pharmacology, the State University of New York at Buffalo. During and shortly after this period, he published his first manuscripts in Nature [9] [10] [11] [12] and Science [13] journals. In 1966, the Faculty Council of the Medical University of Warsaw granted him the degree of Doctor of Medical Sciences (equivalent to a Ph.D.).

Emigration to the United States

One month after the Soviet Union-led Warsaw Pact troops invaded Czechoslovakia in September 1968, Darzynkiewicz left Poland for Sweden on a tourist visa, refused to return, and soon after applied for an immigration visa to the United States. [7] He arrived in the United States in 1969.

Career

From September 1968 to September 1969, Darzynkiewicz was a visiting scientist at the Laboratory of Cell Research, Karolinska Institute, Stockholm, Sweden, working under the supervision of Nils R. Ringertz. [1] [3] [14] [5] In Ringertz's laboratory, Darzynkiewicz met Endre A. Balazs, who offered him a research position in the United States. [14] From 1969 to 1974, Darzynkiewicz worked as a staff scientist at the Department of Connective Tissue Research, Boston Biomedical Research Institute in Boston, MA. From March 1974 to December 1975, he was Research Associate at Memorial Sloan-Kettering Cancer Center, New York, NY. From January 1976 to March 1978, he was an assistant professor, from June 1978 to June 1988, an associate professor, and finally, from July 1988 to September 1990, a full professor at Cornell University, Graduate School of Medical Sciences, New York, NY. From January 1986 to September 1990, he was the Head of the Laboratory of Experimental Cell Research, Memorial Sloan-Kettering Cancer Center.

In October 1990, Darzynkiewicz became a professor of medicine at New York Medical College – a member of the Touro College and University System, [15] [16] Valhalla, NY, and the director of the Brander Cancer Research Institute, New York Medical College. From 1991 he also served as a professor of Microbiology and Immunology and Professor of Pathology at New York Medical College. [1] [7] [17]

Since 1972, the National Institutes of Health, including the prestigious MERIT award, have provided continuous funding for his research. In addition to receiving a NASA grant to develop cell analysis technologies applicable to the microgravity conditions of the International Space Station, his research was also supported by a number of private cancer research foundations. [17]

Darzynkiewicz has published over 780 peer-reviewed articles, [18] has edited, co-edited, and co-authored 15 books, and was granted eight US patents. [19] [20] [21] [22] [23] [24] [25] [26] As of October 2022, his 1992 manuscript entitled "Features of apoptotic cells measured by flow cytometry," published in Cytometry Part A has been cited over 1800 times. [27] [28]

He served as the president of the Cell Cycle Society (1986-1987) and the president of the International Society for Advancement of Cytometry (1993–1994). [29] He was the Editor-in-Chief of the Open Medicine, [30] a co-founder and an Associate Editor of Cytometry Part A , [31] and an Editor of Current Protocols in Cytometry.

Research interests

Darzynkiewicz's research centered on cell biology, with an emphasis on cancer cell growth and the regulatory mechanisms associated with cell growth and cell cycle progression. The most significant scientific contribution made by Darzynkiewicz is his discovery that the process of cell death is equally as significant as the cell cycle, thereby connecting conceptually and methodologically apoptosis to cell division. [3] [28] Darzynkiewicz is also recognized for developing the TUNEL assay (terminal deoxynucleotidyl transferase dUTP nick end labeling), which continues to be one of the most popular methods for measuring apoptosis. [32] He also contributed significantly to the investigation of mechanisms of cell death induced by tumor necrosis factor (TNF). [3] The connection between cell death and cell cycle progression has led Darzynkiewicz and his collaborators to further studies on the cell cycle-dependent effect of anticancer drugs and the death of cells during specific phases of the cell cycle caused by topoisomerase inhibitors and lovastatin. [33] [6]

Selected notable peer-reviewed papers

Honors

His professional affiliations include member (foreign) of the Polish Academy of Sciences [34] and of the Polish Academy of Learning. [35]

Darzynkiewicz was the recipient of an honorary degree from the Medical University of Warsaw in Poland, [36] [7] the Maria Skłodowska-Curie Award from the Jozef Pilsudski Institute in America, [37] and the Casimir Funk Award from the Polish Institute of Arts and Sciences of America. [38]

In 2002 he received Distinguished Service Award from the International Society for Analytical Cytology (ISAC). In 2009 he became a Fellow of the College of American Institute for Medical and Biological Engineering (AIMBE) in recognition for "developing and applying techniques to assess the cell cycle, cell kinetics, cellular apoptosis, tumor response, and progression." [39]

Interactions with Poland

Darzynkiewicz was a founding member of the Kosciuszko Foundation Collegium of Eminent Scientists of Polish Origin and Ancestry, [40] and a trustee of the Kosciuszko Foundation. [41] From 1986 to 1999, he was an advisory board member of The Alfred Jurzykowski Foundation, which annually awarded the Jurzykowski Prize. [42] In 1995 He was a recipient of the Officer's Cross of the Order of Merit of the Republic of Poland. [43]

Zbigniew Darzynkiewicz publications indexed by Google Scholar.

Zbigniew Darzynkiewicz publications indexed by the Scopus bibliographic database. (subscription required)

Related Research Articles

<span class="mw-page-title-main">Apoptosis</span> Programmed cell death in multicellular organisms

Apoptosis is a form of programmed cell death that occurs in multicellular organisms and in some eukaryotic, single-celled microorganisms such as yeast. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, DNA fragmentation, and mRNA decay. The average adult human loses between 50 and 70 billion cells each day due to apoptosis. For an average human child between eight and fourteen years old, each day the approximate loss is 20 to 30 billion cells.

<span class="mw-page-title-main">Flow cytometry</span> Lab technique in biology and chemistry

Flow cytometry (FC) is a technique used to detect and measure physical and chemical characteristics of a population of cells or particles.

<span class="mw-page-title-main">Cyclin</span> Group of proteins

Cyclin is a family of proteins that controls the progression of a cell through the cell cycle by activating cyclin-dependent kinase (CDK) enzymes or group of enzymes required for synthesis of cell cycle.

<span class="mw-page-title-main">Cell death</span> Biological cell ceasing to carry out its functions

Cell death is the event of a biological cell ceasing to carry out its functions. This may be the result of the natural process of old cells dying and being replaced by new ones, as in programmed cell death, or may result from factors such as diseases, localized injury, or the death of the organism of which the cells are part. Apoptosis or Type I cell-death, and autophagy or Type II cell-death are both forms of programmed cell death, while necrosis is a non-physiological process that occurs as a result of infection or injury.

DNA fragmentation is the separation or breaking of DNA strands into pieces. It can be done intentionally by laboratory personnel or by cells, or can occur spontaneously. Spontaneous or accidental DNA fragmentation is fragmentation that gradually accumulates in a cell. It can be measured by e.g. the Comet assay or by the TUNEL assay.

<span class="mw-page-title-main">Propidium iodide</span> Chemical compound

Propidium iodide is a fluorescent intercalating agent that can be used to stain cells and nucleic acids. PI binds to DNA by intercalating between the bases with little or no sequence preference. When in an aqueous solution, PI has a fluorescent excitation maximum of 493 nm (blue-green), and an emission maximum of 636 nm (red). After binding DNA, the quantum yield of PI is enhanced 20-30 fold, and the excitation/emission maximum of PI is shifted to 535 nm (green) / 617 nm (orange-red). Propidium iodide is used as a DNA stain in flow cytometry to evaluate cell viability or DNA content in cell cycle analysis, or in microscopy to visualize the nucleus and other DNA-containing organelles. Propidium Iodide is not membrane-permeable, making it useful to differentiate necrotic, apoptotic and healthy cells based on membrane integrity. PI also binds to RNA, necessitating treatment with nucleases to distinguish between RNA and DNA staining. PI is widely used in fluorescence staining and visualization of the plant cell wall.

<span class="mw-page-title-main">TUNEL assay</span>

Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) is a method for detecting DNA fragmentation by labeling the 3′- hydroxyl termini in the double-strand DNA breaks generated during apoptosis.

<span class="mw-page-title-main">DNA laddering</span>

DNA laddering is a feature that can be observed when DNA fragments, resulting from Apoptosis DNA fragmentation are visualized after separation by gel electrophoresis the first described in 1980 by Andrew Wyllie at the University Edinburgh medical school DNA fragments can also be delected in cells that underwent necrosis, when theses DNA fragments after separation are subjected to gel electrophoresis which in the results in a characteristic ladder pattern,

<span class="mw-page-title-main">Acridine orange</span> Organic dye used in biochemistry

Acridine orange is an organic compound that serves as a nucleic acid-selective fluorescent dye with cationic properties useful for cell cycle determination. Acridine orange is cell-permeable, which allows the dye to interact with DNA by intercalation, or RNA via electrostatic attractions. When bound to DNA, acridine orange is very similar spectrally to an organic compound known as fluorescein. Acridine orange and fluorescein have a maximum excitation at 502nm and 525 nm (green). When acridine orange associates with RNA, the fluorescent dye experiences a maximum excitation shift from 525 nm (green) to 460 nm (blue). The shift in maximum excitation also produces a maximum emission of 650 nm (red). Acridine orange is able to withstand low pH environments, allowing the fluorescent dye to penetrate acidic organelles such as lysosomes and phagolysosomes that are membrane-bound organelles essential for acid hydrolysis or for producing products of phagocytosis of apoptotic cells. Acridine orange is used in epifluorescence microscopy and flow cytometry. The ability to penetrate the cell membranes of acidic organelles and cationic properties of acridine orange allows the dye to differentiate between various types of cells. The shift in maximum excitation and emission wavelengths provides a foundation to predict the wavelength at which the cells will stain.

<span class="mw-page-title-main">DNA damage-inducible transcript 3</span> Human protein and coding gene

DNA damage-inducible transcript 3, also known as C/EBP homologous protein (CHOP), is a pro-apoptotic transcription factor that is encoded by the DDIT3 gene. It is a member of the CCAAT/enhancer-binding protein (C/EBP) family of DNA-binding transcription factors. The protein functions as a dominant-negative inhibitor by forming heterodimers with other C/EBP members, preventing their DNA binding activity. The protein is implicated in adipogenesis and erythropoiesis and has an important role in the cell's stress response.

<span class="mw-page-title-main">Apoptotic DNA fragmentation</span> Cleavage of DNA into tiny pieces during apoptosis

Apoptotic DNA fragmentation is a key feature of apoptosis, a type of programmed cell death. Apoptosis is characterized by the activation of endogenous endonucleases, particularly the caspase-3 activated DNase (CAD), with subsequent cleavage of nuclear DNA into internucleosomal fragments of roughly 180 base pairs (bp) and multiples thereof (360, 540 etc.). The apoptotic DNA fragmentation is being used as a marker of apoptosis and for identification of apoptotic cells either via the DNA laddering assay, the TUNEL assay, or the by detection of cells with fractional DNA content ("sub G1 cells") on DNA content frequency histograms e.g. as in the Nicoletti assay.

<span class="mw-page-title-main">5-Ethynyl-2'-deoxyuridine</span> Chemical compound

5-Ethynyl-2′-deoxyuridine (EdU) is a thymidine analogue which is incorporated into the DNA of dividing cells. EdU is used to assay DNA synthesis in cell culture and detect cells in embryonic, neonatal and adult animals which have undergone DNA synthesis. Whilst at high doses it can be cytotoxic, this molecule is now widely used to track proliferating cells in multiple biological systems.

Cell cycle analysis by DNA content measurement is a method that most frequently employs flow cytometry to distinguish cells in different phases of the cell cycle. Before analysis, the cells are usually permeabilised and treated with a fluorescent dye that stains DNA quantitatively, such as propidium iodide (PI) or 4,6-diamidino-2-phenylindole (DAPI). The fluorescence intensity of the stained cells correlates with the amount of DNA they contain. As the DNA content doubles during the S phase, the DNA content (and thereby intensity of fluorescence) of cells in the G0 phase and G1 phase (before S), in the S phase, and in the G2 phase and M phase (after S) identifies the cell cycle phase position in the major phases (G0/G1 versus S versus G2/M phase) of the cell cycle. The cellular DNA content of individual cells is often plotted as their frequency histogram to provide information about relative frequency (percentage) of cells in the major phases of the cell cycle.

<span class="mw-page-title-main">Lisa Staiano-Coico</span> American academic

Lisa Staiano-Coico or Lisa S. Coico is an American academic. Coico was the twelfth president of City College of New York, from August 2010 until October 2016.

<span class="mw-page-title-main">Mass cytometry</span> Laboratory technique

Mass cytometry is a mass spectrometry technique based on inductively coupled plasma mass spectrometry and time of flight mass spectrometry used for the determination of the properties of cells (cytometry). In this approach, antibodies are conjugated with isotopically pure elements, and these antibodies are used to label cellular proteins. Cells are nebulized and sent through an argon plasma, which ionizes the metal-conjugated antibodies. The metal signals are then analyzed by a time-of-flight mass spectrometer. The approach overcomes limitations of spectral overlap in flow cytometry by utilizing discrete isotopes as a reporter system instead of traditional fluorophores which have broad emission spectra.

An imaging cycler microscope (ICM) is a fully automated (epi)fluorescence microscope which overcomes the spectral resolution limit resulting in parameter- and dimension-unlimited fluorescence imaging. The principle and robotic device was described by Walter Schubert in 1997 and has been further developed with his co-workers within the human toponome project. The ICM runs robotically controlled repetitive incubation-imaging-bleaching cycles with dye-conjugated probe libraries recognizing target structures in situ (biomolecules in fixed cells or tissue sections). This results in the transmission of a randomly large number of distinct biological informations by re-using the same fluorescence channel after bleaching for the transmission of another biological information using the same dye which is conjugated to another specific probe, a.s.o. Thereby noise-reduced quasi-multichannel fluorescence images with reproducible physical, geometrical, and biophysical stabilities are generated. The resulting power of combinatorial molecular discrimination (PCMD) per data point is given by 65,536k, where 65,536 is the number of grey value levels (output of a 16-bit CCD camera), and k is the number of co-mapped biomolecules and/or subdomains per biomolecule(s). High PCMD has been shown for k = 100, and in principle can be expanded for much higher numbers of k. In contrast to traditional multichannel–few-parameter fluorescence microscopy (panel a in the figure) high PCMDs in an ICM lead to high functional and spatial resolution (panel b in the figure). Systematic ICM analysis of biological systems reveals the supramolecular segregation law that describes the principle of order of large, hierarchically organized biomolecular networks in situ (toponome). The ICM is the core technology for the systematic mapping of the complete protein network code in tissues (human toponome project). The original ICM method includes any modification of the bleaching step. Corresponding modifications have been reported for antibody retrieval and chemical dye-quenching debated recently. The Toponome Imaging Systems (TIS) and multi-epitope-ligand cartographs (MELC) represent different stages of the ICM technological development. Imaging cycler microscopy received the American ISAC best paper award in 2008 for the three symbol code of organized proteomes.

Ellen D. Jorgensen is a New York-based molecular biologist leading the do-it-yourself biology movement. She works to increase scientific literacy in the general population, particularly in the fields of molecular and synthetic biology. She is a co-founder of both Biotech Without Borders and Genspace. In 2017, Ellen Jorgensen was named one of the Most Creative Leaders in Business by Fast Company.

Induced cell cycle arrest is the use of a chemical or genetic manipulation to artificially halt progression through the cell cycle. Cellular processes like genome duplication and cell division stop. It can be temporary or permanent. It is an artificial activation of naturally occurring cell cycle checkpoints, induced by exogenous stimuli controlled by an experimenter.

Tissue image cytometry or tissue cytometry is a method of digital histopathology and combines classical digital pathology and computational pathology into one integrated approach with solutions for all kinds of diseases, tissue and cell types as well as molecular markers and corresponding staining methods to visualize these markers. Tissue cytometry uses virtual slides as they can be generated by multiple, commercially available slide scanners, as well as dedicated image analysis software – preferentially including machine and deep learning algorithms. Tissue cytometry enables cellular analysis within thick tissues, retaining morphological and contextual information, including spatial information on defined cellular subpopulations. In this process, a tissue sample, either formalin-fixed paraffin-embedded (FFPE) or frozen tissue section, also referred to as “cryocut”, is labelled with either immunohistochemistry(IHC) or immunofluorescent markers, scanned with high-throughput slide scanners and the data gathered from virtual slides is processed and analyzed using software that is able to identify individual cells in tissue context automatically and distinguish between nucleus and cytoplasm for each cell. Additional algorithms can identify cellular membranes, subcellular structures and/or multicellular tissue structures.

<span class="mw-page-title-main">Joseph Paul Robinson</span> Australian-American scientist and inventor

J. Paul Robinson is an Australian/American educator, biologist, biomedical engineer, and expert in the applications of flow cytometry. He is a Distinguished Professor of Cytometry in the Purdue University College of Veterinary Medicine, Department of Basic Medical Sciences, a professor of Biomedical Engineering in the Weldon School of Biomedical Engineering, a professor of Computer and Information Management at Purdue University, an adjunct professor of Microbiology & Immunology at West Lafayette Center for Medical Education, Indiana University School of Medicine, and the Director of Purdue University Cytometry Laboratories.

References

  1. 1 2 3 "Zbigniew Darzynkiewicz Home Page".
  2. "Kosciuszko Foundation - American Center of Polish culture - In Memoriam Dr. Darzynkiewicz". www.thekf.org. Retrieved 2021-04-28.
  3. 1 2 3 4 Demidenko, Zoya N.; Studzinski, George P.; Blagosklonny, Mikhail V. (2004-05-01). "From Cytometry to Cell Cycle—A Portrait of Zbigniew Darzynkiewicz". Cell Cycle. 3 (5): 523–526. doi: 10.4161/cc.3.5.866 . ISSN   1538-4101. S2CID   33787777.
  4. "Cytometry in Service of Cell Biology and Cancer Research". Purdue Cytometry Volume 10. Retrieved 17 July 2017.
  5. 1 2 Cram, L. Scott; Dobrucki, Jurek W.; Holden, Elena; Jacobberger, James W.; Robinson, J. Paul; Smith, Paul J.; Staiano‐Coico, Lisa; Tarnok, Attila (June 2021). "In memoriam professor Zbigniew Darzynkiewicz ‐ Cytometry pathfinder 1936–2021". Cytometry Part A. 99 (6): 550–556. doi: 10.1002/cyto.a.24357 . ISSN   1552-4922. S2CID   234360832.
  6. 1 2 Darzynkiewicz, Zbigniew (June 2020). "40 Years of My Venture with CYTOMETRY". Cytometry Part A. 97 (6): 557–562. doi: 10.1002/cyto.a.24043 . ISSN   1552-4922. PMID   32511890. S2CID   219550929.{{cite journal}}: CS1 maint: date and year (link)
  7. 1 2 3 4 Skrzypek, Ewa (2016). Poczet doktorów honoris causa (PDF) (in Polish) (2nd ed.). Warsaw, Poland: Rektor Warszawskiego Uniwersytetu Medycznego. p. 387. ISBN   978-83-7637-383-6.
  8. Darżynkiewicz, Zbigniew (2014). "Wystąpienie prof. Zbigniewa Darżynkiewicza podczas ceremonii otrzymania godności doktora honoris causa Warszawskiego Uniwersytetu Medycznego". Medycyna Dydaktyka Wychowanie. Warszawski Uniwersytet Medyczny (published June 2014). XLVI: 3. ISSN   0137-6543.
  9. Darzynkiewicz, Zbigniew; Krassowski, Tadeusz; Skopińska, Ewa (1965). "Effect of Phytohaemagglutinin on Synthesis of 'Rapidly-labelled' Ribonucleic Acid in Human Lymphocytes". Nature (published September 1965). 207 (5004): 1402–1403. Bibcode:1965Natur.207.1402D. doi:10.1038/2071402a0. ISSN   1476-4687. PMID   5886053. S2CID   26980930.
  10. Rogers, A. W.; Darżynkiewicz, Z.; Barnard, E. A.; Salpeter, M. M. (1966). "Number and Location of Acetylcholinesterase Molecules at Motor Endplates of the Mouse". Nature (published June 1966). 210 (5040): 1003–1006. Bibcode:1966Natur.210.1003R. doi:10.1038/2101003a0. ISSN   0028-0836. PMID   5914885. S2CID   4264243.
  11. Darżynkiewicz, Z.; Barnard, E. A. (1967). "Specific Proteases of the Rat Mast Cell". Nature (published March 1967). 213 (5082): 1198–1202. Bibcode:1967Natur.213.1198D. doi:10.1038/2131198a0. ISSN   1476-4687. S2CID   4147097.
  12. Darżynkiewicz, Zbigniew; Dokov, Viktor K.; Pieńkowski, Marek (1967). "Dry Mass of Lymphocytes during Transformation after Stimulation by Phytohaemagglutinin". Nature (published June 1967). 214 (5094): 1265–1266. Bibcode:1967Natur.214.1265D. doi:10.1038/2141265a0. ISSN   1476-4687. PMID   4864010. S2CID   4169702.
  13. Darzynkiewicz, Zbigniew; Rogers, Andrew W.; Barnard, Eric A.; Wang, Dau-Hsi; Werkheiser, William C. (1966-03-25). "Autoradiography with Tritiated Methotrexate and the Cellular Distribution of Folate Reductase". Science. 151 (3717): 1528–1530. Bibcode:1966Sci...151.1528D. doi:10.1126/science.151.3717.1528. ISSN   0036-8075. PMID   5909582. S2CID   10925130.
  14. 1 2 Darzynkiewicz, Zbigniew (2002-07-01). "Tribute to Nils R. Ringertz (1932-2002): Personal Memories". Cell Cycle. 1 (4): 230. doi: 10.4161/cc.1.4.406 . ISSN   1538-4101. S2CID   85395565.
  15. "Zbigniew Darzynkiewicz, M.D., Ph.D. : New York Medical College | Touro College". New York Medical College. Retrieved 2017-07-15.
  16. "Brander Cancer Research Institute : New York Medical College | Touro College". New York Medical College. Retrieved 2017-07-15.
  17. 1 2 Prater, Alicia M. (2012). "An expert probing for answers". Chironian. Valhalla, NY: New York Medical College Office of Public Relations. Spring/Summer: 2–5.
  18. Zbyszek Darzynkiewicz publications indexed by Google Scholar
  19. US4559309A,Evenson, Donald P.&Darzynkiewicz, Zbigniew,"Flow cytometry-fluorescence measurements for characterizing sperm",issued 1985-12-17
  20. US4801550A,Kapuscinski, Jan&Darzynkiewicz, Zbigniew,"Method for separating and analyzing nucleic acids",issued 1989-01-31
  21. US5747258A,Darzynkiewicz, Zbigniew D.; Li, Xun& Traganos, Frank N.et al.,"Detection of halogenated precursors incorporated into DNA",issued 1998-05-05
  22. US5912126A,Darzynkiewicz, Zbigniew; Li, Xun& Traganos, Frank,"Methods for labeling DNA ends with halogenated nucleotides and detecting same with antibodies",issued 1999-06-15
  23. US6417343B1,Darzynkiewicz, Zbigniew; Traganos, Frank& Juan, Gloria,"Physical separation of nucleic acids by antibodies to halogenated nucleotides",issued 2002-07-09
  24. US6821740B2,Darzynkiewicz, Zbigniew; Traganos, Frank& Juan, Gloriaet al.,"Flow cytometric methods for the concurrent detection of discrete functional conformations of PRB in single cells",issued 2004-11-23
  25. US7070943B2,Darzynkiewicz, Zbigniew; Traganos, Frank& Juan, Gloriaet al.,"Detection of protein conformations in single cells",issued 2006-07-04
  26. US7662565B2,Albino, Anthony P.; Jorgensen, Ellen D.& Traganos, Franket al.,"Approaches to identify less harmful tobacco and tobacco products",issued 2010-02-16
  27. "Citation Network In Web of Science Core Collection". Clarivate.
  28. 1 2 Darzynkiewicz, Z.; Bruno, S.; Del Bino, G.; Gorczyca, W.; Hotz, M. A.; Lassota, P.; Traganos, F. (1992). "Features of apoptotic cells measured by flow cytometry". Cytometry. 13 (8): 795–808. doi: 10.1002/cyto.990130802 . ISSN   0196-4763. PMID   1333943.
  29. "Our History". Advancing Cytometry for Over Four Decades.
  30. "Open Medicine". De Gruyter.
  31. Tárnok, Attila (April 2021). "Zbigniew (Zbyszek) Darzynkiewicz 1936–2021". Cytometry Part A. 99 (4): 310. doi: 10.1002/cyto.a.24337 . ISSN   1552-4922. S2CID   232302276.{{cite journal}}: CS1 maint: date and year (link)
  32. Gorczyca, Wojciech; Traganos, Frank; Jesionowska, Hanna; Darzynkiewicz, Zbigniew (1993-07-01). "Presence of DNA Strand Breaks and Increased Sensitivity of DNA in Situ to Denaturation in Abnormal Human Sperm Cells: Analogy to Apoptosis of Somatic Cells". Experimental Cell Research. 207 (1): 202–205. doi:10.1006/excr.1993.1182. ISSN   0014-4827. PMID   8391465.
  33. Demidenko, ZN; Studzinski, GP; Blagosklonny, MV (May 2004). "From cytometry to cell cycle: a portrait of Zbigniew Darzynkiewicz" (PDF). Cell Cycle. 3 (5): 525–8. doi: 10.4161/cc.3.5.866 . PMID   15107608.
  34. "Członkowie Polskiej Akademii Nauk" [Members of the Polish Academy of Sciences] (in Polish). Retrieved 15 July 2017.
  35. "Polska Akademia Umiejętności - Członkowie Wydziału V Lekarskiego". Polska Akademia Umiejętności. Retrieved 2017-07-15.
  36. "Doktorzy Honoris Causa, Universytet Warszawski" . Retrieved Oct 1, 2022.
  37. The Campaign for the Future (PDF) (Report). The Jozef Pilsudski Institute of America. 2014. p. 3.
  38. "PIASA Prominent Members - Past And Present". Piasa.org. Retrieved 2017-07-16.
  39. "Zbigniew Darzynkiewicz, M.D., Ph.D. COF-1162". AIMBE. Retrieved 2017-07-15. For developing and applying techniques to assess the cell cycle, cell kinetics, cellular apoptosis, tumor response and progression.
  40. "EMINENT SCIENTISTS OF POLISH ORIGIN AND ANCESTRY". Thekf.org. Retrieved 2017-07-16.
  41. "BOARD OF TRUSTEES". Thekf.org. Retrieved 2017-07-16.
  42. "The Alfred Jurzykowski Foundation Prizes". The Polish Review. 11 (1): 121–128. 1966. JSTOR   25776649.
  43. Rej 166/95, page 720 Postanowienie Prezydenta Rzeczypospolitej Polskiej z dnia 18 września 1995 o nadaniu orderów i odznaczeń.